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Optimizing theMolecular Weight of Oat β-Glucan for in Vitro Bile Acid
Binding and Fermentation
Hyun Jung Kim and Pamela J. White*
Department of Food Science and Human Nutrition, Iowa State University, Ames, Iowa 50011-1061, United States
ABSTRACT: A previous study showed β-glucan with low molecular weight (MW, 1.56  105 g/mol) bound more bile acid and
produced greater amounts of short-chain fatty acids (SCFA) than did β-glucan with high MW (Mn = 6.87  105 g/mol). In the
current study, β-glucan extracted from oat ﬂour was fractionated into six diﬀerent MW levels (high MW, 7.09  105; low level 1
(L1), 3.48 105; L2, 2.42 105; L3, 1.61 105; L4, 0.87 105; and L5, 0.46 105 g/mol) and evaluated to ﬁnd the optimumMW
aﬀecting in vitro bile acid binding and fermentation. The β-glucan fractions with 2.42 1051.61 105 g/mol (L2 and L3) bound
the greatest amounts of bile acid. After 24 h of fermentation, no diﬀerences were found in total SCFA formation among L1, L2, L3,
and L4 fractions; however, the high MW and L5 MW fractions produced lower amounts of total SCFA. Thus, the optimumMW of
β-glucan to aﬀect both hypocholesterolemic and antitumorigenic in vitro eﬀects was in the range of 2.42 1051.61 105 g/mol.
This MW range also was the most water-soluble among the MWs evaluated.
KEYWORDS: oat β-glucan, molecular weight, in vitro bile acid binding, in vitro fermentation
’ INTRODUCTION
Oat β-glucan is a soluble dietary ﬁber found primarily in the
endosperm cell walls of oats. It has gainedmuch attention resulting
from its health beneﬁts to help regulate blood glucose and insulin
levels, reduce blood cholesterol levels, and control weight through
prolonged satiety.14 In 1997, the U.S. Food and Drug Admin-
istration (FDA) approved a health claim stating that consumption
of β-glucan at a level of 0.75 g per serving in a product may reduce
cholesterol and lower the risk of coronary heart disease.5
β-Glucans are linear homopolysaccharides composed of D-glu-
copyranosyl units linked via amixture ofβ-(1f3) andβ-(1f4) link-
ages. Because β-glucans exhibit consecutive (1f4)-linked β-D-glu-
cose in blocks that are separated by a single (1f3) linkage, they
form viscous solutions.6 The structure and molecular features of
β-glucan, such as the ratio of β-(1f3)/β-(1f4) linkages, ratio
of trimers and tetramers, amounts of longer cellulosic oligomers,
and molecular weight (MW), play important roles in the physical
and physiological functions of β-glucan.7 The MW of β-glucan
determines viscosity, solubility, dispersibility, and gelation prop-
erties, as well as physiological functions in the gastrointestinal
tract.810 The estimated range of MW to be physiologically
active varies between 26,800 and 3,240,000 g/mol,11 depending
upon genetic and environmental factors, isolation and puriﬁca-
tion processes, and the method used for MW estimation.4 The
physiological functions, including cholesterol-lowering and glu-
cose-attenuating eﬀects of β-glucan at diﬀerent ranges of MW,
have been reported.13,7
Studies show mixed results regarding the impact of β-glucan
MW. A clinical study showed that low-density lipoprotein (LDL)
cholesterol of human subjects consuming ready-to-eat breakfast
cereals with 3 g of high MW β-glucan (22.10  105 g/mol) was
lower than that of subjects consuming 4 g of low MW β-glucan
(2.10  105 g/mol), and the eﬃcacy of low MW β-glucan was
reduced by 5%.12 Frank et al.13 reported that β-glucan with low
MW (2.17 105 g/mol) and high MW (7.97 105 g/mol) had
similar cholesterol-lowering eﬀects in human subjects consuming
oat breads made with these β-glucan sources. Some studies
showed cholesterol-lowering eﬀects only from very low MW
β-glucan ((0.700.80) 105 g/mol) consumption.14,15 Tosh et al.16
demonstrated that the glycemic responses of healthy human
subjects consuming oat bran muﬃns containing 4 or 8 g of β-glu-
can improved as the MW increased. Our previous study showed
that β-glucan with lowMW (1.56 105 g/mol) boundmore bile
acid and produced greater amounts of short-chain fatty acids
(SCFA) after 24 h of in vitro fermentation than that with high
MW (6.87 105 g/mol).17 The ﬁndings from studies evaluating
the impact of β-glucan MW on physiological eﬀects are incon-
sistent, with further investigations needed. In the current study,
β-glucan extracted from an experimental oat line developed at
Iowa State University was fractionated to provide six diﬀerent
levels of MW to determine the optimum MW aﬀecting in vitro
bile acid binding, water solubility, and in vitro fermentation
with human fecal ﬂora by using β-glucan extracts with diﬀerent
levels of MW.
’MATERIALS AND METHODS
Preparation of Oat Flour. Experimental oat line (N979-5-4)
developed at Iowa State University and grown in 2009 at the Agronomy
and Agricultural Engineering Field Research Center in Ames, IA, was
chosen for this study because this line had a greater β-glucan concentra-
tion (8%) than publicly available cultivars (45%). The harvested oat
kernels were dried and dehulled with an air-pressure dehuller (Codema,
Eden Prairie, MN). The resulting groats were ground in an ultracen-
trifugal mill (ZM-1, Retch GmbH & Co., Hann, Germany) with a
0.5 mm sieve. Oat flours were then stored at 4 C until used.
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Extraction of β-GlucanMWFractions.Water-solubleβ-glucans
were extracted from oat flours according to the procedure of Yao et al.18
with modification of the enzyme treatment as described. Oat flours were
refluxed with 82% (v/v) ethanol for 2 h at 85 C to inactivate endogenous
enzymes and to remove fat. Starch and protein were removed by heat-
stable R-amylase (200 U/g of oat flour; catalog no. E-BLAAM100;
Megazyme International, Wicklow, Ireland) and pancreatin (1.3 mg/g
of oat flour; catalog no. P-8096; Sigma Aldrich Co., St. Louis, MO). After
ethanol precipitation of polymers, the precipitate was isolated by cen-
trifugation at 3100g for 20min and redissolved in deionizedwater at 80 C
under magnetic stirring. The extracted β-glucan suspension (defined
as high MW β-glucan) was hydrolyzed by using lichenase (330 U of
lichenase/mg of protein; <0.0001 U of β-glucaosidase, cellulose, and
endo-1,3-β-glucanase, and <0.0004U of R-amylase and amyloglucosi-
dases; EC 3.2.1.73, catalog no. E-LICHN, Megazyme), which is a 1,31,
4-β-D-glucan-4-glucanohydrolase and cleaves the 1,4-linkage of the 3-O-sub-
stituted glucose residues in β-glucan to yield lowMW β-glucan fractions.
Lichenase (0.005, 0.025, 0.050, 0.125, and 0.375 U/g of oat flour) was
added to the extracted β-glucan suspension and incubated at 50 C for
20 min to produce different levels of lowMW β-glucan. The hydrolyzed
β-glucan suspensions were heated in a boiling water bath for 10 min
to inactivate the lichenase. After MW determination by HPLC, the
β-glucan suspensions with different MW levels were freeze-dried to
produce high MW and five different levels of lowMW β-glucan fractions.
Three replicates of each extracted β-glucan fraction were prepared and
analyzed.
Determination ofMolecularWeight byHigh-Performance
Liquid Chromatography. The relative MW distribution of the
extracted β-glucans with different levels of MW was determined by using
size exclusion high-performance liquid chromatography (SE-HPLC).19
The SE-HPLC consisted of a solvent delivery module (model 210, ProStar,
Varian Inc., Harbor City, CA), a 100 μL loop injection valve, a guard
column (Ohpak SB-G, Shodex Showa Denko K.K., Tokyo, Japan), three
serially connected columns (Ohpak SB-806 HQ, Ohpak SB-805 HQ,
Ohpak SB-804 HQ; Shodex Showa Denko K.K.), and a refractive index
detector (model 350, ProStar, Varian Inc.). The column temperature
was 40 C, and the flow rate of the mobile phase,Milli-Q water (Milipore,
Bedford, MA) containing 0.02% sodium azide, was 0.5 mL/min.
Aliquots were filtered through a 0.45 μm filter (25 mm i.d., GD/X 25
nylon Syringe Filter, Whatman Inc., Piscataway, NJ) before injection.
β-Glucan MW standards (catalog no. P-MWBG, Megazyme) with MW
values of 3.59 105, 2.45 105, 1.83 105, 1.23 105, and 0.40 105
g/mol were used to estimate the actual MW ranges of the extracted
β-glucan fractions. The peak MW and number-average MW (Mn) were
obtained by a first-order polynomial curve of log MW versus retention
time of the HPLC chromatogram.18
Proximate Composition.Moisture concentration of the extracted
β-glucan was analyzed by using AACCmethod 44-15A.20 The concentra-
tions of β-glucan in extracts weremeasured enzymatically by using AACC
method 32-23, with the application of a Mixed β-glucan linkage kit
(Megazyme). Starch concentration was determined with AACC method
76-13 by using a Total Starch Kit (Megazyme). Proteins were analyzed by
using an automatic nitrogen analyzer (Elementar Analzen SystemGmbH,
Germany) with a nitrogen conversion factor of 6.25. Levels of total,
soluble, and insoluble dietary fiber in extracts were determined by using a
kit (Megazyme) according to AACC method 32-07.20 All analyses were
run in triplicate and the averages reported on a dry weight basis.
Water Solubility.Water solubility of extracted β-glucan with different
MWswas determined according to themethod of Park et al.21 Theβ-glucan
concentration was measured by using AACC method 32-23,20 with the
following minor modification. The β-glucan dispersion in water (1%, w/v)
was agitated at 37 C for 24 h and then centrifuged at 1400g for 20min. The
supernatant was separated, and the concentration of β-glucan in the
supernatant was analyzed. The solubility was calculated as follows: water
solubility (%) = (β-glucan weight dissolved in the supernatant)/(initial
weight of β-glucan in the dispersion)  100.
In Vitro Bile Acid Binding. In vitro bile acid binding of β-glucan
fractions with different MWs was determined by using previously
published procedures.17,22 The bile acid mixture was prepared with
sodium cholate, sodium deoxycholate, sodium glycocholate, and sodium
taurocholate (Sigma-Aldrich Co.) with proportions as 35, 35, 15, and
15% (w/w) in 50 mM phosphate buffer at pH 6.9, respectively.
Cholestyramine (Sigma-Aldrich Co.) was used as a positive and cellulose
(Sigma-Aldrich Co.) as a negative control.22 Fifty milligrams of choles-
tryramine, cellulose, and β-glucan extracts was digested with 1 mL of
0.01 N hydrochloric acid and incubated in a shaking water bath at 37 C
for 1 h, which simulated gastric digestion. The pH of the materials was
then adjusted to 6.9 with 0.1 N sodium hydroxide. Four milliliters of bile
acid mixture (1.4 μmol/mL) and 5 mL of porcine pancreatin (Sigma-
Aldrich Co.; activity at least equivalent to 8  USP specifications;
6.25 mg/mL in a 50 mM phosphate buffer, pH 6.9) were added and
incubated in a shaking water bath at 37 C for 1 h to digest the starch and
protein. After centrifugation at 3100g for 10 min, the supernatant was
removed. An additional 5 mL of phosphate buffer was used to rinse out
the residue, and the mixtures were centrifuged again. The supernatant
was removed and combined with the previous supernatant. Unbound
bile acid in the supernatant was analyzed by using a Bile Acid Diagnostic
Kit (Trinity Biotech, Bray Co., Wicklow, Ireland). The mixtures were
diluted to fall within the range of the test kit. The concentration of bile
acid was calculated on the basis of a standard curve developed from the
bile acid at different concentrations.
In Vitro Fermentation. In vitro fermentation of β-glucan extracts
with different levels of MW was conducted by a batch fermentation
system in an anaerobic environment for 24 h with human fecal flora.17
The inocula were prepared from the fresh feces collected from two
healthy volunteers who had not received antibiotics for at least 3 months
and had not suffered from indigestion problems within the previous
week. The fermentation medium was prepared immediately by diluting
feces (1:3, w/v) with brainheart infusion (BHI; Difco Laboratories,
Detroit, MI) medium according to the method of Zheng et al.23
Homogeneous fecal slurries were filtered through four layers of cheese-
cloth, and 2 mL of filtered inocula was added to each serum bottle
containing 100 mg of β-glucan extracts prehydrated in 8 mL of BHI
medium overnight at 4 C. The headspace of the bottle was flushed with
CO2, and the serum bottles were sealed with PTFE/silicone septa and
aluminum caps (Supelco Inc., Bellefonte, PA). The bottles were
incubated in a shaking water bath at 37 C for 0, 2, 4, 8, 12, and 24 h.
A blank without any substrate and lactulose (Sigma-Aldrich Co.) as a
completely fermentable substrate were prepared as controls. Total gas
production was measured by the overpressure in the headspace of the
bottle by using a digital manometer (Fisher Scientific, Pittsburgh, PA).
Fermentation was terminated by adding 100 μL of saturated mercury
chloride (HgCl2) solution, and the pH was measured. The fermented
mixture was then centrifuged at 3100g for 10 min, and a 1 mL aliquot
from the supernatant was removed for SCFA analysis.
Short-Chain Fatty Acid (SCFA) Analysis. SCFAs, including
acetate, propionate, butyrate, valerate, isobutyrate, and isovalerate, were
analyzed according to the method described in Sayar et al.19 A 1 mL
aliquot of fermentation solution wasmixed with 100μL of 2-ethylbutyric
acid as an internal standard and acidified by 0.5 mL of hydrochloric acid.
The SCFA was extracted with 3 mL of diethyl ether, and 1 mL of ether
layer was transferred and derivatized by 100 μL of N-(tert-
butyldimethylsilyl)-N-methyltrifluoroacetamide (MTBSTFA; Sigma-
Aldrich Co.) at 80 C for 20 min. After 24 h of standing at room
temperature to complete derivatization, 1 μL of silylated derivative was
injected into a HP 5890 GC (Hewlett-Packard, Palo Alto, CA) equipped
with a flame ionization detector. The column was an SPB-5 (30 m 
0.25 mm i.d.  1 μm df; Supelco Inc.), and helium was used as carrier
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gas. The oven temperature was kept at 70 C for 3 min and programmed
to increase to 160 C at 7 C/min and stay for 5 min. The injector and
detector temperatures were 220 and 250 C, respectively. SCFAs were
identified by comparison with known fatty acid standards (Sigma-
Aldrich Co.) and quantified by using the peak area ratio of the analyte
to the internal standard.
Statistical Analysis. Data were analyzed by using the analysis of
variance (ANOVA), followed by least significant differences (LSD) for
comparison among different MW fractions of β-glucan by using the GLM
procedure in SAS version 9.1 (SAS Institute, Cary, NC) at R = 0.05.
’RESULTS AND DISCUSSION
Characterization of β-GlucanMWFractions.TheMW) and
composition of high and low MW (L1L5) β-glucan fractions
extracted from oat flour are shown (Table 1). The number-
averageMW (Mn) and peakMWof β-glucan extracts were deter-
mined from the peak retention time and area of the SE-HPLC
chromatograms after hydrolysis. The Mn and peak MW of the
highMW β-glucan fraction were 7.09 105 and 8.98 105 g/mol,
respectively, which were similar to the values of high MW β-glu-
can (6.87 105 and 9.50 105 g/mol) in our previous study.17
TheMn of the high MW β-glucan fraction was greatly decreased
to 3.48  105, 2.42  105, 1.61  105, 0.87  105, and 0.46 
105 g/mol for L1, L2, L3, L4, and L5 MW fractions, respectively
(p < 0.05), by using different amounts of lichenase treatment.
The peak MW of β-glucan fractions at different MW levels
differed (p < 0.05). The β-glucan extracts were prepared to
provide more MW divisions than in our previous study to better
isolate the optimum MW of β-glucan providing maximum
physiological effects.17 The peak MW of the high MW β-glucan
fraction in the current study was lower (8.98 105 g/mol) than
those from other studies (10.020.0 105 g/mol).3,24,25 These
different values might be attributed to oat type, environmental or
growth factors, andmethods used for extraction, purification, and
determination.25 In the current study, the extraction procedure
with hot water and added thermostable R-amylase may cause the
presence of small fractions of β-glucan with lower peak MW in
the extracts.26 The estimated MW also can vary according to the
standards used in the SE-HPLC procedure. For example, in the
current study, we used β-glucan calibration standards obtained
from Megazyme ((0.43.59)  105 g/mol), whereas, in our
study by Yao et al.,18 we used pullulan standards ((0.4816.6)
105 g/mol) to evaluate the same oat line, N979-5-4, grown in the
years 2002, 2003, and 2004, obtaining peak MWs of 41.2  105,
38.5 105, and 31.6 105 g/mol instead of the 8.98 105 g/mol
in the current study. Although the peak MW of the high MW
β-glucan fraction in the current study was lower than those of
other studies reported, the viscosity of high MW β-glucan
suspension (1%w/v) wasmuch greater (peak viscosity = 7986 cP)
than those of the other lowMW fractions (551331 cP, data not
shown); thus, the MW range represented in the current study
provided appropriate materials for evaluation.
The extracted β-glucan fractions with diﬀerent MWs con-
tained 8592% β-glucan, which was greater than in our previous
study (64.166.6%).17 In the current study, the amounts of
thermostable R-amylase and pancreatin during β-glucan extrac-
tion from oat ﬂour were increased from 130 U/g of oat ﬂour and
1mg/g of oat ﬂour to 200 U/g and 1.3 mg/g, respectively. Likely,
the increased amounts of enzymes to remove starch and protein
helped to extract and yield greater concentrations of β-glucan
from oat ﬂour. Several studies also reported that the extraction
yield of β-glucan varies depending on the techniques, such as
solvents, temperature, incubation condition, and time.24,25
The starch and protein concentrations in the extracts were
1.21.6 and 1.52.0%, respectively (p > 0.05) (Table 1), as most
of the starch and protein in the oat ﬂour were removed during
treatment with R-amylase and pancreatin. Insoluble dietary ﬁber
(IDF) and soluble dietary ﬁber (SDF) including β-glucan were
3.23.7 and 89.492.2%, respectively. Most of the contents in
the extracted β-glucan MW fractions were SDF, that is, β-glucan.
The diﬀerences between SDF and β-glucan concentrations
ranged from 0.6 to 4.9%. Other complex carbohydrates, such
as resistant oligosaccharides, might not be measured by either of
the methods for β-glucan analysis or SDF analysis.27
Water Solubility of β-Glucan MW Fractions. The water
solubility of the extracted β-glucan fractions with high, L1, L2,
L3, L4, and L5 MW were 56.9, 82.2, 83.4, 87.3, 80.8, and 79.8%,
respectively (Table 2). The highMW β-glucan fraction dissolved
in water at a much lower concentration than the lower MW β-
glucan fractions. The high MW β-glucan had a lower diffusion
rate in solution,28 which lowered its solubility. As the MW of β-
glucan decreased, the water solubility increased initially but
decreased later. The β-glucan with the lowest MW of 0.46 
105 g/mol had the lowest solubility among the lowMW β-glucan
fractions. This was also observed in the study of Tosh et al.16 The
tendency of cereal β-glucan molecules to associate in aqueous
solutions has been reported.29,30 Once the molecules are suffi-
ciently low in size to become mobile enough in solution, they
Table 1. Molecular Weight Distributions and Chemical Composition of the Extracted β-Glucan Fractions with Diﬀerent
Molecular Weights
compositiona (%, dry weight basis)
MWa ( 105g/mol) dietary ﬁber
β-glucan MW fraction Mn
b peak MW β-glucan starch protein SDFc IDFd
high 7.09( 0.44 a 8.98( 0.50 a 89.0( 3.9 ab 1.4( 0.3 1.5( 0.4 90.9( 3.5 3.5( 0.8
L1 3.48( 0.77 b 4.87( 1.07 b 86.3( 1.6 ab 1.5( 0.2 1.7( 0.2 91.0 ( 1.7 3.4( 0.6
L2 2.42( 0.04 c 2.79( 0.07 c 88.7( 4.5 ab 1.4( 0.5 1.6( 0.2 89.4( 4.1 3.6( 0.2
L3 1.61( 0.23 cd 1.80( 0.09 cd 84.6( 2.2 b 1.6( 0.3 1.8( 0.3 89.5 ( 5.1 3.3( 0.9
L4 0.87( 0.06 d 0.91( 0.02 d 91.6( 3.6 a 1.4( 0.4 1.6( 0.2 92.2( 1.5 3.7( 0.2
L5 0.46( 0.20 e 0.53( 0.28 e 88.5( 1.0 ab 1.2( 0.2 1.9( 0.3 91.0 ( 2.5 3.2( 0.5
aValues are the mean ( standard deviation. Values followed by diﬀerent letters within a column are signiﬁcantly diﬀerent (p < 0.05). bNumber-
average MW. c Soluble dietary ﬁber including β-glucan. d Insoluble dietary ﬁber.
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diffuse into a position where they can aggregate with each other
like the formation of a gel.16 Likely, the β-glucan molecules of L4
and L5 MW fractions aggregated together, resulting in lower
water solubility.
In Vitro Bile Acid Binding.The total amount of bile acid initially
added in tests of in vitro bile acid binding of cholestryramine,
cellulose, and high and lowMW β-glucan fractions was 11.2 μmol/
100 mg of treatment (Table 2). The positive control, cholestyr-
amine, a component of a drug frequently used to treat hyperlipide-
mia, bound 10.77 μmol of bile acid/100 mg of cholestyramine. The
negative control, cellulose, a nonbinding bile acid fiber, bound only
0.04 μmol of bile acid/100 mg of cellulose. If the amount bound
by cholestyramine were considered to bind bile acid at 100%,
then the amount bound by cellulose would be calculated as 0.4%
(= 0.04 μmol/10.77 μmol100%). These values of both controls
are similar to the results given for cholestyramine and cellulose in
other studies.22,31
The relative bile acid binding values of high and lowMW β-glu-
can fractions were calculated on the basis of 100% bile acid bound
to cholestyramine to eliminate methodological eﬀects. Values
were 22.8, 28.1, 31.0, 30.8, 27.8, and 21.7% for high, L1, L2, L3,
L4, and L5 MW β-glucan, respectively (Table 2). The bile acid
binding values also were calculated on the basis of 100 mg of
β-glucan (Table 2) to evaluate the eﬀect of MW on bile acid
binding to β-glucan. The high MW and the lowest MW (L5)
β-glucan fractions bound the least amount of bile acid per 100mg
of total weight and per 100 mg of β-glucan among all fractions
(p < 0.05). The L2 (2.42  105 g/mol) and L3 MW (1.61 
105 g/mol) β-glucan fractions bound greater amounts of bile acid
per 100 mg of total weight and per 100 mg of β-glucan than the
high MW and L5 MW fractions. The high MW and the lowest
MW (L5) β-glucan fractions bound the least amount of bile acid
among all fractions (p < 0.05). The L2 (2.42  105 g/mol) and
L3 MW (1.61  105 g/mol) β-glucan fractions bound greater
amounts of bile acid than the rest of the β-glucan fractions. The
major component of β-glucan fractions with diﬀerent MW levels
was β-glucan, a SDF (Table 1); thus, the diﬀerent bile acid
binding values of β-glucan extracts could be mostly attributed to
the β-glucan component.
The relative bile acid binding values (converted on the basis
of 100% bile acid binding to cholestyramine) per 100 mg of
β-glucan at diﬀerent averageMWs (Mn) obtained from the current
study and our previous study results17 were combined (Figure 1) to
demonstrate the optimumMW of β-glucan for bile acid binding.
As theMWof β-glucan decreased, the bile acid binding increased
initially and decreased later in a pattern similar to that of water
solubility (Table 2). These data suggest that the low solubility
of β-glucan resulted in low bile acid binding. The low mobility of
the high MW β-glucan fraction and the high self-aggregation of
the lowestMW β-glucan (L5) likely reduced the bile acid binding
to β-glucan. Our results indicated that the optimum MW of
β-glucan providing the greatest bile acid binding, under the
conditions presented, ranged from 1.61 105 to 2.42 105 g/mol,
demonstrating the importance of determining solubility, in addi-
tion to MW, for the formulation and development of oat-
containing food products to obtain a desired physiological eﬀect.
Bile acids synthesized in the liver from cholesterol are reab-
sorbed and transported to the liver, where they are extracted
eﬃciently and again secreted into the bile, a process described
as enterohepatic circulation.32 Therefore, eliminating bile acids
from the circulation or reducing the reabsorption of bile acids
consumes cholesterol and lowers the serum cholesterol level.
Table 2. Water Solubility and in Vitro Bile Acid Binding of the Extracted β-Glucan Fractions with Diﬀerent Molecular Weights
bile acid bounda
β-glucan
MW fraction
water
solubilitya,b (%)
μmol/100
mg total,c dwb
relative % to
cholestyramined
μmol/100 mg
β-glucan,e dwb
relative % to
cholestyramined
cholestyramine 10.77( 0.07 a 100.00 10.77( 0.07 a 100.00
cellulose 0.04( 0.01 d 0.33 0.04( 0.01 d 0.33
high 56.9( 5.3 b 2.45( 0.58 c 22.79 2.76( 0.66 c 25.64
L1 82.2( 1.3 a 3.03( 0.03 bc 28.09 3.51( 0.03 bc 32.57
L2 83.4( 3.0 a 3.33( 0.30 b 30.95 3.77( 0.53 b 35.01
L3 87.3( 1.4 a 3.32( 0.18 b 30.79 3.87( 0.14 b 35.90
L4 80.8( 2.2 a 2.99( 0.52 bc 27.78 3.28( 0.71 bc 30.48
L5 79.8( 3.4 a 2.34( 0.52 c 21.70 2.64( 0.57 c 24.50
aValues are the mean ( standard deviation. Values with diﬀerent letters within a column are signiﬁcantly diﬀerent (p < 0.05). b% β-glucan solublized
in water. cCalculated on the basis of 100mg total sample weight of cholestyramine, cellulose, and extractedβ-glucanwith diﬀerentMWs. dRelative bile acid
binding percentage (%)when cholestyramine is considered to bind 100%bile acid. eCalculated on the basis of 100mg ofβ-glucan in the extractedβ-glucan.
Figure 1. Relative bile acid binding percentage of β-glucan extracts with
diﬀerent average MWs. Relative bile acid binding values (%) were
calculated by assuming a bile acid binding value of cholestyramine
of 100%.
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Likely, β-glucan lowers the cholesterol level by preventing bile
acid reabsorption in the ileum, thus increasing bile acid excretion
in the feces,31,32 although itsmechanism of interaction in bile acid
binding still needs further investigation.
In Vitro Fermentation. Progress of in vitro fermentation of the
blank, lactulose, and β-glucan MW fractions (L1L5) measured
by pH changes, gas production, and total SCFA formation during
0, 2, 4, 8, 12, and 24 h of fermentation is shown (Figure 2 and
Table 3). Included were a blank with no substrates as a negative
standard, and lactulose, a positive standard for complete fermenta-
tion in the colon. The pH of all treatments decreased rapidly
between 0 and 4 h of fermentation, followed by a slight increase
toward the end of fermentation (24 h, Figure 2). The pH of
lactulose dropped sharply to pH 5.0. The pH of β-glucan extracts
with different MWs decreased from 6.46.5 to 5.35.4, with no
differences among MW fractions. This pH drop resulted from
SCFA formation during fermentation.33 The slight increase in the
pH after 4 h of fermentation may be attributed to the production
of different metabolites in the media, such as ammonia.34 The
low pH caused by the production of SCFA can promote positive
physiological effects in the colon, such as preventing colon cancer
and protecting against pathogenic bacteria.35 Total gas production
of all treatments increased as fermentation proceeded from 0 to
24 h (Figure 2). Lactulose and β-glucan MW fractions produced
greater amounts of gas than did the blank, but did not differ from
each other. These results of pH and gas production are consistent
with those observed for whole oat flour and purified β-glucan with
high MW in other studies.17,19
Total SCFA formation from the blank, lactulose, and β-glucan
MW fractions continuously increased as fermentation time
increased from 0 to 24 h (Table 3). The production of SCFA
lowered pH and was highly correlated (R = 0.9) to total gas
production during in vitro fermentation. Lactulose tended to
produce fewer SCFA than did the β-glucanMW fractions, except
for the L5 MW β-glucan fraction. After 24 h of fermentation,
there were no diﬀerences in total SCFA formation among L1, L2,
L3, and L4 MW fractions; however, the high MW and L5 MW
fractions produced lower amounts of total SCFA than the other
MW β-glucan fractions (Table 3). Therefore, β-glucan fractions
in the range of 0.87  1053.48  105 g/mol MW produced
Figure 2. pH changes and total gas production during in vitro fermentation of the blank, lactulose, and the extracted β-glucan fractions with
diﬀerent MWs.
Table 3. Total Short-Chain Fatty Acid (SCFA) Production during in Vitro Fermentation of the Extracted β-Glucan with Diﬀerent
Molecular Weights
total SCFAa (mM) at a fermentation time of
β-glucan MW fraction 0 h 2 h 4 h 8 h 12 h 24 h
blank 2.1( 0.2 8.3( 0.2 b 15.2 ( 0.2 b 18.5( 0.2 b 24.4( 0.2 d 29.9( 2.1 c
lactulose 2.0( 0.1 11.8( 0.9 a 21.3( 2.4 a 24.1( 0.1 ab 30.5( 0.1 bc 34.8( 1.0 b
high 2.1( 0.2 10.4( 1.3 ab 20.6( 2.3 a 23.4( 0.2 ab 32.3( 1.2 abc 34.0( 2.6 b
L1 2.1( 0.1 9.7( 1.9 ab 20.3( 0.9 a 27.0( 0.2 a 33.5( 1.2 ab 36.9( 1.4 a
L2 1.9( 0.3 9.7( 0.8 ab 21.0( 0.4 a 23.3( 0.2 ab 34.8( 1.9 a 36.8( 1.9 a
L3 2.0( 0.1 10.1( 2.0 ab 21.4 ( 0.6 a 26.6( 0.5 a 35.2( 1.3 a 36.5( 2.8 a
L4 2.2( 0.1 9.7( 1.0 ab 21.2( 0.9 a 24.4( 0.2 ab 32.3( 1.2 abc 37.3( 1.6 a
L5 2.0( 0.1 9.7( 1.4 ab 18.2( 0.1 ab 20.8( 0.1 ab 28.2( 1.0 cd 33.0( 2.0 bc
aValues are the mean ( standard deviation. Values with diﬀerent letters within a column are signiﬁcantly diﬀerent (p < 0.05).
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greater amounts of SCFA than did those at high or lowMW after
24 h of fermentation. Acetate, propionate, and butyrate, among all
SCFAs, were the main SCFAs, and small amounts of isobutyrate,
valerate, and isovalerate were produced from all treatments during
in vitro fermentation (Figure 3). The total of the three main
SCFAs accounted for 9094% of the total SCFAs produced.
Acetate was produced in the greatest amount, followed by butyrate
and propionate. The β-glucan extracts tended to produce more
propionate than did lactulose, and the L2, L3, and L4 MW
fractions produced greater amounts than the high and L5 MW
β-glucan fractions (Figure 3).
Some health beneﬁts of β-glucan are attributed to the produc-
tion of SCFAs.4,9,35 The SCFAs taken up from the colon are
metabolized to contribute to energy needs. Acetate is known as
the main metabolite and the primary substrate for cholesterol
synthesis.9 The production of propionate has been reported to
lower blood glucose and insulin levels and raise high-density
lipoprotein (HDL) cholesterol and triglycerides.3638 Rectal
infusions of propionate reduced serum cholesterol, whereas
acetate alone increased serum cholesterol.39 Butyrate also has
gained attention for its potential to promote colon health, as it is
the preferred metabolic substance for colonocytes.4 Health
beneﬁts of β-glucans suggested by the SCFA proﬁles during in
vitro fermentation would likely be aﬀected by the molecular
features of the oat β-glucans (Table 3 and Figure 3). Our previous
study showed that the lowMWβ-glucan fraction (1.56 105 g/mol)
produced greater quantities of SCFA than the high MW (6.87
105 g/mol) after 24 h of fermentation.17 In the current study, the
low MW β-glucan fractions (0.87  1053.48  105 g/mol)
produced greater SCFAs than the high MW β-glucan; however,
the lowest MW β-glucan fraction (0.46  105 g/mol) produced
less total SCFAs than fractions having slightly greater MW.
These SCFA results positively correlated with water solubility
and in vitro bile acid binding (Table 2). The low solubility of the
lowestMW β-glucan fraction was related to both in vitro bile acid
binding (R= 0.8) and SCFAproduction during in vitro fermentation
(R = 0.7). The solubility (or dispersion) of β-glucan has been
reported to be responsible for the biological activity of β-glucan.8,40
Cheng et al.41 noted that increased water solubility can enhance
the physiological activities of β-glucan.
β-Glucan fractions, containing 8592% of β-glucan from oat,
were treated with lichenase to contain diﬀerent MWs. The highest
(7.09 105 g/mol) and lowestMW(0.46 105 g/mol) β-glucans
bound less bile acid than did the L2 (2.42  105 g/mol) and L3
(1.61 105 g/mol) β-glucanMW fractions. No diﬀerences were
found in total SCFA formation amongL1, L2, L3, andL4 fractions,
havingMWs of 0.87 1053.48 105 g/mol, respectively, after
24 h of in vitro fermentation. The high and L5 MW fractions
produced the lowest amounts of SCFAs. These physiological
eﬀects of β-glucan fractions were related to the water solubility of
β-glucan: the high MW fraction had the lowest water solubility
values. The optimum MW of β-glucan to provide potential
biological function, under the conditions of this study, ranged
from 2.42  105 to 1.61  105 g/mol, lower than the high MW,
that is, the original MW of β-glucan in oat. This study demon-
strated the importance of knowing both the solubility andMWof
β-glucan in the development and formulation of food products to
obtain a desired physiological eﬀect.
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